nifoMorph Competitors

We do not just develop and deliver innovative medicines. We bring together ambitious, collaborative and courageous people who are committed to finding ways to treat cancer differently. MorphoSys began as a research and development technology provider 30 years ago, which positioned us as a valuable partner to pharmaceutical manufacturers worldwide. This empowered our evolution into a fully integrated biopharmaceutical company, and our growth over the past 15 years can only be attributed to the dedicated and passionate people driving our mission forward: More life for people with cancer. Explore our open positions and learn more about our core values, mission and work at www.morphosys.com. For additional information on our community guidelines, please visit https://www.morphosys.com/en/community-guidelines

Oral integrin therapies for patients with immunological, fibrotic, neoplastic and vascular diseases. Morphic Tx is joining a three decade quest led by our scientific founder, Tim Springer, who initially discovered the integrin receptor family in the 1980s. This receptor family is an important drug target that has fueled the successful development of six injectable therapies approved for treatment of multiple sclerosis, ulcerative colitis, Crohn's disease, plaque psoriasis, acute coronary syndrome and complications during percutaneous coronary intervention. Despite blockbuster commercial success, integrins have remained out of reach as small molecule drugs...until now.

Xenomorph provides trusted data management solutions to many of the world’s leading financial institutions. The company has more than two decades’ experience managing large volumes of complex data and analytics. Over that time, we have consistently reinvested in our technology, culminating in our latest generation enterprise data management platform. Our software is built to be future-proof. With our rules-based single-stack architecture, flexible data model, easily configurable workflow engine and integrated feature updates, the Xenomorph data management platform empowers you to address any future requirements. It can be operated by business users without any prior programming expertise, which means it offers a truly agile and cost effective solution to address evolving business, regulatory and technology trends. The platform also excels at managing and validating model-derived data, thereby enabling firms to address their model risk management challenges by making sure inputs and outputs of business critical models are always validated and kept in sync. For more information on our company, our clients, services and solutions, please visit www.xenomorph.com or contact us at info@xenomorph.com.